Merck Enters into Unique World Licensing Settlement for LaNova Medicines’ LM-299
https://www.tipranks.com/information/company-announcements/dr-reddys-laboratories-allocates-equity-shares-to-employees Merck (MRK) introduced the closing of the unique international licensing settlement…
Blueprint Medicines’ Continued Leadership in Redefining the Standard of Care in Systemic Mastocytosis Highlighted at 2024 ASH Annual Meeting
-- ASH data reinforce survival benefits of front-line AYVAKIT ® (avapritinib) use…
